BRCA1或BRCA2突变女性中年龄特异性卵巢癌风险
该研究基于国际注册库中5689名无既往卵巢癌或输卵管癌诊断及预防性卵巢切除术的女性,估算BRCA1或BRCA2突变携带者年龄特异性卵巢癌发病率。平均随访4.7年(范围0-22.6)期间诊断195例卵巢癌或输卵管癌,BRCA1突变携带者至80岁累积风险为49%,BRCA2为21%。基于至35岁累积风险0.55%(BRCA1)和至45岁0.56%(BRCA2),作者推荐BRCA1突变女性在40岁前但理想为35岁行双侧输卵管卵巢切除术,BRCA2突变女性在45岁前手术。
要点
- BRCA1突变携带者至80岁卵巢癌累积风险为49%,BRCA2为21%。
- BRCA1突变携带者平均诊断年龄51.3岁(范围33-84),BRCA2为61.4岁(范围44-80)。
- 作者推荐BRCA1突变女性40岁前(理想35岁)行双侧输卵管卵巢切除术,BRCA2女性45岁前手术。
核心结论
- 基于BRCA1突变携带者至35岁累积风险0.55%和BRCA2突变携带者至45岁累积风险0.56%,作者推荐BRCA1突变女性在40岁前但理想为35岁行双侧输卵管卵巢切除术,BRCA2突变女性在45岁前手术,以最大化预防并最小化不良效应。
研究设计与样本
- 从国际注册库中识别5689名无既往卵巢癌或输卵管癌诊断及预防性卵巢切除术的女性,从基线问卷完成日期随访至卵巢癌或输卵管癌诊断、预防性卵巢切除术、死亡或末次随访。
主要发现
- 平均随访4.7年(范围0-22.6)期间诊断195例卵巢癌或输卵管癌,其中卵巢癌169例(86%)、输卵管癌22例(11%)、同时累及卵巢和输卵管4例(2%)。
- 195例中45例(23%)在预防性手术时诊断(隐匿癌)。
- BRCA1突变携带者至80岁卵巢癌累积风险为49%,BRCA2突变携带者为21%。
- BRCA1突变携带者平均诊断年龄为51.3岁(范围33-84),BRCA2突变携带者为61.4岁(范围44-80)。
关键数值与推荐
- BRCA1突变携带者至35岁累积风险为0.55%,BRCA2突变携带者至45岁累积风险为0.56%。
临床怎么用
- 作者推荐BRCA1突变女性在40岁前但理想为35岁行双侧输卵管卵巢切除术,BRCA2突变女性在45岁前手术。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: For women at high risk of developing ovarian cancer, it is important to provide an accurate recommendation for the optimal age for preventive surgery in order to maximize the preventative effect while delaying symptoms associated with early surgical menopause. The goal of the current study was to estimate age-specific incidence rates of ovarian cancer among women with a BRCA1 or BRCA2 mutation. METHODS: From our international registry, we identified 5689 women with no previous diagnosis of ovarian or fallopian tube cancer or preventive oophorectomy. Women were followed from the date of completion of the baseline questionnaire until either a diagnosis of ovarian or fallopian tube cancer, prophylactic oophorectomy, death or last follow-up. The annual and cumulative incidence rates of ovarian cancer were estimated. RESULTS: Over a mean follow-up period of 4.7 years (ranges 0-22.6), 195 incident ovarian or fallopian tube cancers were diagnosed (169 [86%] ovarian cancers, 22 [11%] fallopian tube cancers and four [2%] cancers that involved both the ovaries and fallopian tubes). Of these, 45 (23%) cancers were diagnosed at preventive surgery (occult cancers). The cumulative risk of ovarian cancer to age 80 was 49% for BRCA1 and 21% for BRCA2 mutation carriers. The mean age at diagnosis was 51.3 years (ranges 33-84) among women with a BRCA1 mutation and 61.4 years (ranges 44-80) among women with a BRCA2 mutation. CONCLUSION: Based on a cumulative risk of 0.55% to age 35 for BRCA1 mutation carriers and of 0.56% to age 45 for BRCA2 mutation carriers, we recommend bilateral salpingo-oophorectomy before age 40, but ideally by age 35, for women with a BRCA1 mutation and by age 45 for those with a BRCA2 mutation to maximize prevention and to minimize adverse effects.
引用
- Kotsopoulos J, Gronwald J, Karlan B, et al. Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation. Gynecol Oncol. 2018. PMID: 29793803. doi:10.1016/j.ygyno.2018.05.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。